Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Should not yet alter nephropathy management in hypertension or diabetes; extends mechanistic literature and leaves open the need for interventional trials.
John D. Imig (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: